SURMODICS INC — Director's Dealing 2018

Sep 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2018-09-04

Reporting Person: Maharaj Gary R (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-04	Common Stock	S	3700	$79.4007	Disposed	171579	Direct
2018-09-04	Common Stock	S	1300	$80.1639	Disposed	170279	Direct

Footnotes

F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2018.

F2: Reflects the weighted average price of 3,700 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on September 4, 2018 with sale prices ranging from $78.90 to $79.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Includes 693 shares acquired through the Employee Stock Purchase Plan for the phase ending August 31, 2018.

F4: Reflects the weighted average price of 1,300 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on September 4, 2018 with sale prices ranging from $79.95 to $80.40 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.